Universal Vision Biotechnology Co., Ltd. (3218) Stock Price & Analysis
3218 Stock Chart & Stats
- Day’s Range
- TWD 115.50 - TWD 126.50
- 52-Week Range
- TWD 115.50 - TWD 161.00
- Previous Close
- TWD 124.50
- Volume
- N/A
- Average Volume (3M)
- 131.01K
- Market Cap
- TWD 10.72B
- Enterprise Value
- TWD 12.14B
- Total Cash (Recent Filing)
- TWD 1.03B
- Total Debt (Recent Filing)
- TWD 1.51B
- Price to Earnings (P/E)
- 9.4
- Beta
- 0.41
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 26, 2026
- Dividend Yield
- 6.13%
3218 FAQ
What was Universal Vision Biotechnology Co., Ltd.’s price range in the past 12 months?
What is Universal Vision Biotechnology Co., Ltd.’s market cap?
When is Universal Vision Biotechnology Co., Ltd.’s upcoming earnings report date?
How were Universal Vision Biotechnology Co., Ltd.’s earnings last quarter?
Is Universal Vision Biotechnology Co., Ltd. overvalued?
Does Universal Vision Biotechnology Co., Ltd. pay dividends?
What is Universal Vision Biotechnology Co., Ltd.’s EPS estimate?
How many shares outstanding does Universal Vision Biotechnology Co., Ltd. have?
What happened to Universal Vision Biotechnology Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Universal Vision Biotechnology Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Universal Vision Biotechnology Co., Ltd.
Universal Vision Biotechnology Co., Ltd., established in 1992 and based in Taipei, Taiwan, manages a network of eye care clinics across both Taiwan and China. The company delivers a comprehensive range of ophthalmic services, encompassing advanced surgical interventions and treatments for various ocular conditions. Its surgical specialties include laser vision correction for common refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related vision decline). They also perform intraocular lens procedures for presbyopia and cataracts, employing advanced techniques like phacoemulsification and femtosecond laser surgery. Beyond surgical solutions, Universal Vision addresses a wide spectrum of eye health concerns, offering services for myopia control, dry eye syndrome, retinal detachment, macular degeneration, strabismus (crossed eyes), amblyopia (lazy eye), and numerous other ophthalmic ailments. The company further provides a diverse array of vision products and optical aids, including various eyeglass frames, specialized multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, and both conventional and colored contact lenses. Nutritional eye supplements are also available. Additional offerings include oculoplastic and micro cosmetic eye surgery, alongside bespoke aesthetic medicine consultations. Furthermore, Universal Vision engages in optometric services, hospital administration, technical advisory roles, and the distribution and rental of medical equipment.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Zhenghong Lu
- Employees
- 401
- Website
- www.uvb.com.tw
- Address
- Building G, Taipei, TP, 115, TW
Universal Vision Biotechnology Co., Ltd. (3218) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 5 | 12 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 2 | 0 | 10 |

